Get started
Author

D.F. Archer

Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society
2007 · Wulf H. Utian, D.F. Archer, et al. · 232
91203543 Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol
1991 · R.T. Scott, B. Ross, et al. · Maturitas · 53
Drospirenone and estradiol: a new option for the postmenopausal woman
2007 · D. F. Archer · Climacteric · 29
Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis
1998 · J. H. Pickar, F. Bottiglioni, et al. · Climacteric · 12
91257926 Endometrial morphology in asymptomatic postmenopausal women
1992 · D.F. Archer, K. McIntyre-Seltman, et al. · Maturitas · 12
67 Safety and Tolerability of Bazedoxifene/conjugated Estrogens in Postmenopausal Women: Findings From a 1 -year, Randomized, Placebo- and Active-controlled, Phase 3 Trial
2012 · S. Mirkin, D.F. Archer, et al. · Maturitas · 10
Effects of a contraceptive patch and 3 oral contraceptives on follicular development following incorrect dosing
2000 · R.A. Pierson, A.R. Hess, et al. · International Journal of Gynecology & Obstetrics · 8
Effect of Intravaginal Prasterone (dhea) on Libido and Sexual Dysfunction in Postmenopausal Women
2009 · C. Bouchard, D. Archer, et al. · Maturitas · 5
An integrated assessment of patient compliance with a weekly contraceptive patch (ORTHO EVRA™/EVRA™).
2001 · D. Archer, A. Bigrigg, et al. · Fertility and Sterility · 4
Increased compliance with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive (COC) in a phase 3 clinical trial
2012 · A. Kaunitz, D.F. Archer, et al. · Contraception · 3
Contraceptive efficacy, safety and acceptability of SILCS, a novel single-sized diaphragm used with contraceptive gel
2012 · J.L. Schwartz, D. Weiner, et al. · Contraception · 3
A Contraceptive Patch is Significantly More Effective than Oral Contraceptives (OCs) in Suppressing Follicular Development
2000 · R.A Pierson, D.F Archer, et al. · Fertility and Sterility · 3
Serum Steroid Levels During 12-week Intravaginal Dhea Administration
2009 · F. Labrie, D. Archer, et al. · Maturitas · 2
Intravaginal Prasterone (dhea), a Highly Efficient and the Only Physiological Treatment of Vaginal Atrophy
2009 · F. Labrie, D. Archer, et al. · Maturitas · 2
P3.13.08 Effects of progestin dose and time since menopause on endometrial bleeding with continuous combined hormone replacement therapy
2000 · D.F. Archer, J.H. Pickar · International Journal of Gynecology & Obstetrics · 2
Poster Presentation
1994 · D. F. Archer, J. H. Pickar · Menopause The Journal of The North American Menopause Society · 2
Cervicovaginal colposcopic lesions associated with nonoxynol-9 spermicide use versus condom use in a low-risk population
2006 · B. Harwood, L.A. Meyn, et al. · Contraception · 1
Re: Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
2000 · D. F. Archer · JNCI Journal of the National Cancer Institute · 1
P50 A randomized and single-blinded comparative trial of two different-sized copper iuds to examine bleeding, cramping, and satisfaction/acceptability in a predominantly nulliparous population: 6 week results
2020 · K. O’Connell White, J. Kerns, et al. · Contraception
Activity of CYP3A4 and CYP2C19 in Young Women Who Use Depot Medroxyprogesterone Acetate (DMPA) [23N]
2016 · Thomas Kimble, Jennifer Sager, et al. · Obstetrics and Gynecology
Prostaglandin F2 alpha is a product of the decidualized human stromal cell
2013 · D.F. Archer, J.E. Taylor, et al. · Fertility and Sterility
Evaluation of exposure to ethinyl estradiol (EE) with a low dose combination transdermal contraceptive delivery system (AG200-15) compared to low-dose combination oral contraceptive
2010 · D.F. Archer, F.Z. Stanczyk, et al. · Fertility and Sterility
PDF
P-169
2006 · S. Mirkin, G. Kovalevsky, et al. · Fertility and Sterility
PDF
P-168
2006 · D.F. Archer, S. Mirkin, et al. · Fertility and Sterility
Raloxifene (Rlx) Effects on Vascular Endothelial Growth Factor (VEGF) and Thrombospondin-1 (TSP-1) Are Not Mediated by Changes in Steroid Receptor (SR) Co-Repressors or Co-Activators or Cell Proliferation Markers in a Human Endometrial Cell Line
2005 · S.M. Bocca, D.F. Archer · Fertility and Sterility
PDF
Works count: 38
Citation count: 384
H-index: 7
I10-index: 6
Year
Topic
Type